LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Co-Diagnostics Inc

Fermé

SecteurSoins de santé

0.27 -15.62

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.27

Max

0.32

Chiffres clés

By Trading Economics

Revenu

-197K

-7.7M

Ventes

113K

163K

Marge bénéficiaire

-4,745.023

Employés

132

EBITDA

-526K

-7.8M

Dividendes

By Dow Jones

Prochains Résultats

6 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.2M

13M

Ouverture précédente

15.89

Clôture précédente

0.27

Sentiment de l'Actualité

By Acuity

39%

61%

130 / 371 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bearish Evidence

Co-Diagnostics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 sept. 2025, 23:07 UTC

Acquisitions, Fusions, Rachats

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 sept. 2025, 22:10 UTC

Principaux Mouvements du Marché

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 sept. 2025, 21:47 UTC

Résultats

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 sept. 2025, 16:52 UTC

Principaux Mouvements du Marché

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 sept. 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 sept. 2025, 21:40 UTC

Acquisitions, Fusions, Rachats

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 sept. 2025, 21:07 UTC

Résultats

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 sept. 2025, 21:07 UTC

Résultats

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Rev $17.35B >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q EPS 82c >ATD.T

2 sept. 2025, 21:05 UTC

Résultats

Couche-Tard 1Q Net $782.5M >ATD.T

2 sept. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2 sept. 2025, 20:53 UTC

Market Talk
Acquisitions, Fusions, Rachats

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 sept. 2025, 20:51 UTC

Acquisitions, Fusions, Rachats

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 sept. 2025, 20:27 UTC

Résultats

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 sept. 2025, 20:24 UTC

Acquisitions, Fusions, Rachats

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 sept. 2025, 20:18 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 sept. 2025, 20:17 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 sept. 2025, 20:16 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 sept. 2025, 20:16 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 sept. 2025, 20:15 UTC

Acquisitions, Fusions, Rachats

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 sept. 2025, 19:55 UTC

Résultats

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 sept. 2025, 19:50 UTC

Acquisitions, Fusions, Rachats

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 sept. 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 sept. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 sept. 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2 sept. 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 sept. 2025, 16:57 UTC

Acquisitions, Fusions, Rachats

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Comparaison

Variation de prix

Co-Diagnostics Inc prévision

Note du Consensus

By TipRanks

Neutre

1 ratings

0

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

0.3495 / 0.3699Support & Résistance

Court Terme

Bearish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

130 / 371Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.